» Articles » PMID: 37142193

NMR Sample Optimization and Backbone Assignment of a Stabilized Neurotensin Receptor

Overview
Journal J Struct Biol
Date 2023 May 4
PMID 37142193
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors (GPCRs) are involved in a multitude of cellular signaling cascades and consequently are a prominent target for pharmaceutical drugs. In the past decades, a growing number of high-resolution structures of GPCRs has been solved, providing unprecedented insights into their mode of action. However, knowledge on the dynamical nature of GPCRs is equally important for a better functional understanding, which can be obtained by NMR spectroscopy. Here, we employed a combination of size exclusion chromatography, thermal stability measurements and 2D-NMR experiments for the NMR sample optimization of the stabilized neurotensin receptor type 1 (NTR1) variant HTGH4 bound to the agonist neurotensin. We identified the short-chain lipid di-heptanoyl-glycero-phosphocholine (DHPC) as a promising membrane mimetic for high resolution NMR experiments and obtained a partial NMR backbone resonance assignment. However, internal membrane-incorporated parts of the protein were not visible due to lacking amide proton back-exchange. Nevertheless, NMR and hydrogen deuterium exchange (HDX) mass spectrometry experiments could be used to probe structural changes at the orthosteric ligand binding site in the agonist and antagonist bound states. To enhance amide proton exchange we partially unfolded HTGH4 and observed additional NMR signals in the transmembrane region. However, this procedure led to a higher sample heterogeneity, suggesting that other strategies need to be applied to obtain high-quality NMR spectra of the entire protein. In summary, the herein reported NMR characterization is an essential step toward a more complete resonance assignment of NTR1 and for probing its structural and dynamical features in different functional states.

Citing Articles

NMR spectroscopy reveals insights into mechanisms of GPCR signaling.

Silva L, Wijesekara A, Eddy M Trends Biochem Sci. 2024; 50(1):84-85.

PMID: 39523165 PMC: 11698642. DOI: 10.1016/j.tibs.2024.10.007.


Efficient Segmental Isotope Labeling of Integral Membrane Proteins for High-Resolution NMR Studies.

Daniilidis M, Sperl L, Muller B, Babl A, Hagn F J Am Chem Soc. 2024; 146(22):15403-15410.

PMID: 38787792 PMC: 11157531. DOI: 10.1021/jacs.4c03294.


Two-Dimensional NMR Spectroscopy of the G Protein-Coupled Receptor AAR in Lipid Nanodiscs.

Guo C, Yang L, Liu Z, Liu D, Wuthrich K Molecules. 2023; 28(14).

PMID: 37513291 PMC: 10383251. DOI: 10.3390/molecules28145419.

References
1.
Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M . Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther. 1997; 280(2):802-12. View

2.
Mohammad Nezhady M, Rivera J, Chemtob S . Location Bias as Emerging Paradigm in GPCR Biology and Drug Discovery. iScience. 2020; 23(10):101643. PMC: 7569339. DOI: 10.1016/j.isci.2020.101643. View

3.
Pritisanac I, Wurz J, Alderson T, Guntert P . Automatic structure-based NMR methyl resonance assignment in large proteins. Nat Commun. 2019; 10(1):4922. PMC: 6820720. DOI: 10.1038/s41467-019-12837-8. View

4.
Rosenbaum D, Rasmussen S, Kobilka B . The structure and function of G-protein-coupled receptors. Nature. 2009; 459(7245):356-63. PMC: 3967846. DOI: 10.1038/nature08144. View

5.
Shimada I, Ueda T, Kofuku Y, Eddy M, Wuthrich K . GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nat Rev Drug Discov. 2018; 18(1):59-82. PMC: 6681916. DOI: 10.1038/nrd.2018.180. View